This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4r69
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4r69' size='340' side='right'caption='[[4r69]], [[Resolution|resolution]] 3.19Å' scene=''> | <StructureSection load='4r69' size='340' side='right'caption='[[4r69]], [[Resolution|resolution]] 3.19Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4r69]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4r69]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R69 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4R69 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EPE:4-(2-HYDROXYETHYL)-1-PIPERAZINE+ETHANESULFONIC+ACID'>EPE</scene>, <scene name='pdbligand=NAI:1,4-DIHYDRONICOTINAMIDE+ADENINE+DINUCLEOTIDE'>NAI</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=W13:(5R)-2-[(2-CHLOROPHENYL)SULFANYL]-5-[2,6-DICHLORO-3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PHENYL]-3-HYDROXYCYCLOHEX-2-EN-1-ONE'>W13</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EPE:4-(2-HYDROXYETHYL)-1-PIPERAZINE+ETHANESULFONIC+ACID'>EPE</scene>, <scene name='pdbligand=NAI:1,4-DIHYDRONICOTINAMIDE+ADENINE+DINUCLEOTIDE'>NAI</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=W13:(5R)-2-[(2-CHLOROPHENYL)SULFANYL]-5-[2,6-DICHLORO-3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PHENYL]-3-HYDROXYCYCLOHEX-2-EN-1-ONE'>W13</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4r69 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r69 OCA], [https://pdbe.org/4r69 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4r69 RCSB], [https://www.ebi.ac.uk/pdbsum/4r69 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4r69 ProSAT]</span></td></tr> | |
| - | + | ||
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/LDHA_HUMAN LDHA_HUMAN] Defects in LDHA are the cause of glycogen storage disease type 11 (GSD11) [MIM:[https://omim.org/entry/612933 612933]. A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue.<ref>PMID:2334430</ref> |
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/LDHA_HUMAN LDHA_HUMAN] | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 22: | ||
==See Also== | ==See Also== | ||
| - | *[[Lactate | + | *[[Lactate dehydrogenase 3D structures|Lactate dehydrogenase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | + | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Eigenbrot | + | [[Category: Eigenbrot C]] |
| - | [[Category: Ultsch | + | [[Category: Ultsch M]] |
| - | + | ||
Revision as of 06:41, 2 March 2023
Lactate Dehydrogenase in complex with inhibitor compound 13
| |||||||||||
